Amitriptyline
4 customer reviewsAmitriptyline is a tricyclic antidepressant used for depression, nerve pain, and migraine prevention. It is for adults who need help with mood symptoms, anxiety features, or chronic pain with poor sleep. It works by increasing serotonin and norepinephrine signalling in the brain.
What is it?
Amitriptyline is a tricyclic antidepressant used to treat depression, and it can also manage nerve pain, migraines, and certain sleep disorders. It is prescribed for adults who need help with mood symptoms, anxiety features, or chronic pain conditions where sleep is also disrupted. It works by increasing serotonin and norepinephrine signalling in the brain, which can lift mood and reduce pain sensitivity.
Composition
Amitriptyline contains amitriptyline hydrochloride as the active substance. The tablets may also include standard excipients such as lactose, starch, cellulose, povidone, magnesium stearate, and other inert ingredients that support tablet formation and stability.
How to use?
Amitriptyline dosing is individual. The right dose depends on the condition being treated, age, other medicines, and how strongly sedation or dry mouth shows up.
A practical way clinicians use it is “start low, then adjust upward in steps” until benefit appears or side effects limit further increases. For depression, dosing may be given as a single night-time dose or split across the day. For chronic pain, the dose is usually lower than for depression, with the aim of reducing pain flares and improving sleep continuity.
Concrete administration points that matter:
- Swallow the tablet with water; food is optional.
- If sedation is a problem, evening dosing is often preferred.
- Consistency matters more than timing by minutes; taking it at the same time each day reduces missed doses.
- If you miss a dose, take it when remembered unless it is close to the next scheduled dose; avoid doubling up.
How does it work?
- Oral use only. Swallow the tablet with water.
- Depression and related symptoms: start with 25 mg 2–3 times/day or 75 mg once at bedtime; if needed, increase gradually to 150–200 mg/day in divided doses. Take the larger dose at bedtime because of drowsiness. Duration is usually several weeks to months as prescribed.
- Neuropathic pain: take 10–25 mg orally at bedtime; if needed, increase by 10–25 mg every few days to 25–75 mg/day. Duration is typically weeks to months.
- Migraine prevention: take 10–25 mg orally at bedtime, then increase if required to 25–50 mg/day. Use daily for several weeks before assessing benefit.
- Functional gastrointestinal pain or irritable bowel symptoms: take 10–25 mg orally at bedtime; titrate slowly if prescribed, usually not exceeding 75 mg/day. Duration is often several weeks to months.
- With or after food: the tablets can be taken with food or after meals if stomach upset occurs; bedtime dosing is preferred when possible.
Indications
Amitriptyline belongs to the tricyclic antidepressants (TCAs), a well-established class of antidepressants used in major depressive disorder and other mood disorders. In day-to-day practice, it is also used when a patient’s symptoms overlap: low mood plus poor sleep, or chronic pain plus anxiety, where a sedating medicine can be a practical fit.
Beyond depression, clinicians often use Amitriptyline for chronic pain syndromes where the nervous system amplifies pain signals. Examples include neuropathic pain (nerve pain), migraine prevention, and neuralgia. Evidence summaries and prescribing standards support its recognised role as a TCA with antidepressant and analgesic effects [1].
Amitriptyline’s pain benefit is real for many patients because the same brain pathways that influence mood also tune pain processing.
Comparison
Alternatives depend on the main goal: mood improvement, nerve pain control, migraine prevention, or sleep support. Newer antidepressants such as SSRIs and SNRIs are often chosen first for depression because they tend to cause less dry mouth and constipation, while SNRIs are frequently selected when pain symptoms are prominent.
Non-prescription supplements like 5-HTP are sometimes discussed online, but they can still carry serotonergic interaction risk and they do not replace prescription-grade treatment plans for depression or neuropathic pain.
What Amitriptyline offers is strong sedation and dual mood–pain benefit in a single TCA, balanced against more anticholinergic side effects than many newer antidepressants.
| Option | How it tends to feel in real life | Typical trade-off |
|---|---|---|
| Amitriptyline (TCA) | more sedating, more dry mouth/constipation | useful for sleep + nerve pain; more interaction burden |
| SSRIs (newer antidepressants) | less sedating for many people | sexual side effects and GI upset can be limiting |
| SNRIs (newer antidepressants) | can help mood and pain | can raise blood pressure or cause sweating in some |
Guidance pathways used in systems influenced by the EMA and NICE often position TCAs as valuable choices when first-line options fail, when pain is prominent, or when sleep is a key symptom to target [3].
Contraindications
Amitriptyline is not for you if any of the following apply:
- Allergy or hypersensitivity to Amitriptyline.
- Recent acute myocardial infarction.
- Significant heart rhythm disorders such as heart block or clinically important arrhythmia.
- Angle-closure glaucoma.
- Current manic or hypomanic episodes.
Extra caution is used in epilepsy, significant liver disease, and in people with a history of suicidal thoughts or behaviours, since antidepressants can alter activation early in treatment. Pregnancy and breastfeeding require a prescriber-led risk–benefit decision.
Not recommended for
Some conditions make Amitriptyline a poor fit, because TCAs can affect heart rhythm, eye pressure, and urinary outflow. Risk is higher when someone has multiple interacting medicines or underlying cardiac disease.
Amitriptyline is not for you if any of the following apply:
- Allergy or hypersensitivity to Amitriptyline.
- Recent acute myocardial infarction.
- Significant heart rhythm disorders such as heart block or clinically important arrhythmia.
- Angle-closure glaucoma.
- Current manic or hypomanic episodes.
Side effects
Side effects often show up early, then soften as the body adjusts. They are common at the start. The most common issues are linked to the anticholinergic and sedative effects typical of TCAs: sleepiness, dry mouth, constipation, dizziness, blurred vision, and urinary hesitation. Weight gain can occur with longer-term use, and some patients notice an increased appetite.
Less common but higher-stakes reactions include fast or irregular heartbeat, fainting, severe confusion, eye pain with sudden visual changes (a concern for angle-closure glaucoma), or signs of allergy such as swelling and rash. Mood can also shift in vulnerable patients, including agitation or manic symptoms.
A simple way to think about side effects is “dry, slow, sleepy”: dry mouth, slowed gut movement, and sleepiness.
Common mistakes
Amitriptyline is a medicine where small habits change tolerability.
- Taking the first doses on nights before early shifts or long drives, then blaming the medicine for daytime sedation rather than the timing.
- Doubling a missed dose “to catch up,” which increases dizziness, palpitations, and confusion risk.
- Using it for sleep and adding other sedatives on top (strong antihistamines, sleep aids, or alcohol), then feeling unsteady the next day.
- Stopping suddenly after weeks or months, which can cause rebound insomnia, nausea, and irritability in some people.
- Expecting immediate mood lift within one or two doses; for depression, benefits are usually gradual.
One sentence that saves trouble: sedation is a predictable effect, not an allergy.
Doctor opinions
In clinical practice, doctors often reach for Amitriptyline when a patient describes “tired but wired” sleep, pain that flares at night, and mood symptoms that are worsened by exhaustion. Psychiatrists value it as a tricyclic antidepressant option when other antidepressants have not worked or caused unwanted activating effects, while neurologists may use it in migraine prevention when sleep quality is part of the migraine pattern.
Prescribers also respect its limitations. Cardiac history changes the decision quickly, and many clinicians will check for rhythm risk factors and interacting medicines before titrating. When the plan is pain control rather than antidepressant effect, many doctors keep doses modest and focus on functional goals like fewer night awakenings and fewer pain-triggered flare days.
Frequently asked questions
Alcohol can intensify sedation and dizziness from Amitriptyline, which raises fall risk and next-day impairment. The combination also makes it harder to judge if the dose is too strong during the first weeks. Many clinicians advise avoiding alcohol during titration and keeping intake minimal once stable, because the effect is unpredictable person to person. WHO guidance on medicines and alcohol highlights additive CNS depression as a key safety concern with sedating drugs [4].
For depression, mood benefits usually build over a few weeks of consistent dosing rather than after the first tablet. For nerve pain or sleep continuity, some people notice improvement earlier, but it can still take weeks to reach a stable effect. A common pattern is sedation first, then symptom improvement later. Product information for amitriptyline-class TCAs reflects this delayed therapeutic onset in depressive disorders [5].
Weight gain can happen with Amitriptyline, most often over longer use. Appetite increase, improved sleep, and reduced activity from sedation can all contribute. The practical fix is to anticipate it early: plan evening snacks, keep hydration up, and monitor weekly weight trends rather than waiting months. Antidepressant tolerability discussions often include weight change as a meaningful factor in long-term adherence decisions .
Amitriptyline can slow reaction time and cause morning grogginess, mainly at the start or after dose increases. This matters for driving, operating machinery, and safety-sensitive work. Many prescribers schedule dose changes before quieter days off, so the patient can learn how their body reacts. Medication safety counselling places strong emphasis on impairment risk with sedating medicines, even when the medicine is otherwise well tolerated .
Amitriptyline in pregnancy or breastfeeding is a prescriber-led decision based on symptom severity and alternative options. Some patients need ongoing treatment, while others can switch or taper under supervision. The key medical issue is balancing maternal mental health (and function) against potential fetal or neonatal exposure. Careful risk–benefit assessment is recommended rather than blanket rules .
Stopping suddenly can trigger rebound insomnia, nausea, irritability, and a return of pain or mood symptoms. A gradual taper is commonly used in practice, with smaller dose reductions as you get closer to zero. Patients often find the last steps hardest, because sleep can wobble again for a week or two. Deprescribing discussions around psychotropic medicines emphasise gradual reduction to minimise discontinuation symptoms .
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Amitriptyline — Comparison with alternatives
Amitriptyline Current Best price
Anafranil
Zoloft
Pristiq Best rated
Paxil
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2023). Amitriptyline — Summary of Product Characteristics (SmPC). ↑
- MOHAP (Ministry of Health and Prevention) (2025). Medication Safety and Pharmacovigilance Guidance for Healthcare Professionals. ↑
- National Institute for Health and Care Excellence (NICE) (2025). Depression in adults: treatment and management (guideline). ↑
- World Health Organization (WHO) (2025). WHO guidance on the use of psychoactive medicines and central nervous system depressants. ↑
- U.S. Food and Drug Administration (FDA) (2024). Amitriptyline Hydrochloride Tablets, Prescribing Information. ↑